161 related articles for article (PubMed ID: 36048146)
1. Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer.
Thomas AS; Kwon W; Horowitz DP; Bates SE; Fojo AT; Manji GA; Schreibman S; Schrope BA; Chabot JA; Kluger MD
J Surg Oncol; 2022 Dec; 126(8):1442-1450. PubMed ID: 36048146
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
[TBL] [Abstract][Full Text] [Related]
3. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
Kwon D; McFarland K; Velanovich V; Martin RC
Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
[TBL] [Abstract][Full Text] [Related]
4. Irreversible electroporation in locally advanced pancreatic cancer.
Polyakov AN; Patyutko YI; Kudashkin NE; Kantieva DM; Romanova KA; Nasonova EA; Korshak AV; Egenov OA; Podluzhnyi DV
Khirurgiia (Mosk); 2023; (10):29-38. PubMed ID: 37916555
[TBL] [Abstract][Full Text] [Related]
5. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
Martin RC; McFarland K; Ellis S; Velanovich V
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
[TBL] [Abstract][Full Text] [Related]
6. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
Simmerman E; Chung J; Lawson A; Kruse E
J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
[TBL] [Abstract][Full Text] [Related]
7. Irreversible Electroporation-Assisted Resection for Locally Advanced Pancreas Cancer.
Davis JM; Salibi PN; Motz BM; Vrochides D; McKillop IH; Iannitti DA
Surg Innov; 2023 Jun; 30(3):332-339. PubMed ID: 36792137
[TBL] [Abstract][Full Text] [Related]
8. Irreversible electroporation to bring initially unresectable locally advanced pancreatic adenocarcinoma to surgery: the IRECAP phase II study.
Tasu JP; Herpe G; Damion J; Richer JP; Debeane B; Vionnet M; Rouleau L; Carretier M; Ferru A; Ingrand P; Tougeron D
Eur Radiol; 2024 Mar; ():. PubMed ID: 38494526
[TBL] [Abstract][Full Text] [Related]
9. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
10. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
[TBL] [Abstract][Full Text] [Related]
11. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
[TBL] [Abstract][Full Text] [Related]
12. Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC).
Oikonomou D; Karamouzis MV; Moris D; Dimitrokallis N; Papamichael D; Kountourakis P; Astras G; Davakis S; Papalampros A; Schizas D; Petrou AS; Felekouras E
Am J Clin Oncol; 2021 Jul; 44(7):325-330. PubMed ID: 33979098
[TBL] [Abstract][Full Text] [Related]
13. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
Marsanic P; Mellano A; Sottile A; De Simone M
Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
[TBL] [Abstract][Full Text] [Related]
14. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
Martin RC; McFarland K; Ellis S; Velanovich V
J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemotherapy alone versus irreversible electroporation followed by chemotherapy on survival in patients with locally advanced pancreatic cancer.
Belfiore G; Belfiore MP; Reginelli A; Capasso R; Romano F; Ianniello GP; Cappabianca S; Brunese L
Med Oncol; 2017 Mar; 34(3):38. PubMed ID: 28161827
[TBL] [Abstract][Full Text] [Related]
16. Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial.
Rai ZL; Ranieri V; Palmer DH; Littler P; Ghaneh P; Gurusamy K; Manas D; Pizzo E; Psarelli EE; Gilmore R; Peddu P; Bartlett DC; de Liguori Carino N; Davidson BR
BMJ Open; 2022 May; 12(5):e050166. PubMed ID: 35551086
[TBL] [Abstract][Full Text] [Related]
17. Margin ACcentuation for resectable Pancreatic cancer using Irreversible Electroporation - Results from the MACPIE-I study.
Kundalia K; Hakeem A; Papoulas M; Mcphail M; Reddy S; Peddu P; Kibriya N; Atkinson S; Prachalias A; Srinivasan P; Heaton N; Sarker D; Ross P; Zen Y; Menon K
Eur J Surg Oncol; 2021 Oct; 47(10):2571-2578. PubMed ID: 34039473
[TBL] [Abstract][Full Text] [Related]
18. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
[TBL] [Abstract][Full Text] [Related]
19. Irreversible electroporation after induction chemotherapy versus chemotherapy alone for patients with locally advanced pancreatic cancer: A propensity score matching analysis.
He C; Wang J; Zhang Y; Lin X; Li S
Pancreatology; 2020 Apr; 20(3):477-484. PubMed ID: 32131993
[TBL] [Abstract][Full Text] [Related]
20. Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival.
Woeste MR; Wilson KD; Kruse EJ; Weiss MJ; Christein JD; White RR; Martin RCG
Front Oncol; 2021; 11():817220. PubMed ID: 35096621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]